Cooperative Agreement 72044020CA00002

This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program is intended to scale up and improve the management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The $287,878,180 award, with a project period from October 1, 2024 to September 30, 2029, will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance to...

The U.S. Agency for International Development (USAID) awarded a $6,480,574 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to Tropical Disease Foundation Inc. (TDF), a foreign-owned non-profit organization based in the Philippines. The project, titled "TUBERCULOSIS-FREE VISAYAS AND MINDANAO," aims to control and prevent the spread of tuberculosis in the Visayas and Mindanao regions of the Philippines over a 5-year period from January...

This $7,000,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program supports actions to fight tuberculosis (TB) in the Philippines over a 5-year period from October 2024 to September 2029. The project, titled "ACTIONS TO SUPPORT WIDE-SCALE INTERVENTIONS TO FIGHT TB IN THE PHILIPPINES (ACT SWIFT)", will be implemented by the Philippine Tuberculosis Society, Inc. This award...

This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...

This federal Cooperative Agreement award, valued at $4,650,276 and granted by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to reduce the tuberculosis (TB) burden and establish a sustainable and responsive care system in Kyrgyzstan. The primary awardee, JSI Research & Training Institute Inc., will lead efforts focused on early screening, diagnosis, personalized treatment, and patient support across...

The U.S. Agency for International Development (USAID) awarded a $6,925,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to University Research Co., LLC to implement the "TB-FREE LUZON ACTIVITY" in the Philippines. The five-year project, with a start date of September 26, 2024 and a completion date of September 25, 2029, aims to strengthen tuberculosis (TB) prevention and control services in the Luzon region of the Philippines....

The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region within five years. The award, granted to the Dutch non-profit organization Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), will support technical expertise,...

This $550,000 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Global Tuberculosis (TB): Developing, Evaluating, Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally program (CFDA 93.494), is funding a five-year collaboration between the CDC and the Union Internationale Contre la Tuberculose et les Maladies Respiratoires (Uitmr), an international non-profit organization based in Paris, France. The...

This Cooperative Agreement award, valued at $4,003,313.00, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The purpose of this 5-year award, running from October 2024 to September 2029, is to increase access to and sustainability of quality tuberculosis (TB) diagnosis, treatment, and prevention services in Cambodia through three key objectives: 1) Effective linkages to the healthcare system,...

<p>This $2,557,380.00 Cooperative Agreement was awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program. The funding supports a five-year project focused on tuberculosis (TB) prevention and response activities in Zimbabwe, beginning on October 1, 2024 and concluding on September 30, 2029. The prime awardee for this grant is the non-profit organization The Union Zimbabwe Trust, based in Harare, Zimbabwe.</p>